Suppr超能文献

医师改性血管内移植物治疗破裂性主动脉弓夹层动脉瘤。

Physician Modified Endograft for Ruptured Dissecting Aortic Arch Aneurysm.

机构信息

Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Vasc Endovascular Surg. 2024 Nov;58(8):876-883. doi: 10.1177/15385744241276599. Epub 2024 Aug 20.

Abstract

BACKGROUND

Endovascular repair of thoracic aortic aneurysms (TAA) in elective settings has demonstrated successful clinical outcomes. However, life-threatening conditions such as rupture are more often managed with open surgical repair due to the high complexity of arch endovascular repair, lack of available off-the-shelf devices, and limited long-term data.

CASE SUMMARY

A 49-year-old female with a recent history of prior ascending aortic repair for Type A aortic dissection presented with chest pain and dyspnea. Chest computed tomography angiogram (CTA) revealed acute bilateral pulmonary emboli and a 6.2 cm post dissection aneurysm of the posterior aortic arch with the dissection extending to the right iliac artery. She was treated with thrombolysis and subsequently became hemodynamically unstable. Repeat CTA revealed a massive left hemithorax with concern for aortic arch rupture. Given significant cardiorespiratory compromise and recent open repair, she was considered unfit for redo open repair. Thoracic endovascular aortic repair (TEVAR) with a physician-modified endograft (PMEG) was planned. An Alpha Zenith endograft was modified adding an internal branch for the innominate artery and a fenestration for the left common carotid artery. The left subclavian artery was occluded with a microvascular plug and coil embolization up to the level of the vertebral artery. TEVAR PMEG extension to the celiac artery was performed followed by deployment of a Zenith dissection stent to the aortic bifurcation. Completion angiogram demonstrated successful aneurysm exclusion and patency of target vessels.

CONCLUSION

Endovascular treatment of ruptured TAA with PMEGs is feasible. This approach may be an alternative for unfit patients for open repair in emergent settings.

摘要

背景

在择期情况下,胸主动脉瘤(TAA)的血管内修复已显示出成功的临床结果。然而,由于弓部血管内修复的高度复杂性、可用的现成器械缺乏以及有限的长期数据,危及生命的情况,如破裂,更常通过开放手术修复来治疗。

病例摘要

一名 49 岁女性,既往有升主动脉A型主动脉夹层修复史,因胸痛和呼吸困难就诊。胸部 CT 血管造影(CTA)显示急性双侧肺栓塞和后主动脉弓 6.2cm 夹层后动脉瘤,夹层延伸至右侧髂动脉。她接受了溶栓治疗,随后出现血流动力学不稳定。重复 CTA 显示左侧大量胸腔,考虑主动脉弓破裂。鉴于心肺功能严重受损和最近的开放修复,她被认为不适合再次进行开放修复。计划进行胸主动脉血管内修复(TEVAR)和医师改良血管内移植物(PMEG)。对 AlphaZenith 血管内移植物进行了修改,增加了一个用于无名动脉的分支和一个用于左颈总动脉的开窗。左锁骨下动脉通过微栓子和线圈栓塞闭塞至椎动脉水平。进行了 TEVAR PMEG 向腹腔动脉的延伸,随后在主动脉分叉处部署了 Zenith 夹层支架。完成血管造影显示动脉瘤成功排除,目标血管通畅。

结论

使用 PMEG 对破裂性 TAA 进行血管内治疗是可行的。这种方法可能是不适合紧急情况下开放修复的患者的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b4/11440784/36ce90fc87a3/10.1177_15385744241276599-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验